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Pregnancy is a condition exhibiting increased susceptibility to oxidative stress, and Fe plays a central role in generating harmful oxygen species.
The objective of the present study is to investigate the changes in haematological status, oxidative stress and erythrocyte membrane fluidity in
anaemic pregnant women after Fe supplementation with and without combined vitamins. The study was a 2 months double-blind, randomised
trial. Pregnant women (n 164) were allocated to four groups: group C was the placebo control group; group I was supplemented daily with
60 mg Fe (ferrous sulphate) daily; group IF was supplemented daily with Fe plus 400mg folic acid; group IM was supplemented daily with Fe
plus 2 mg retinol and 1 mg riboflavin, respectively. After the 2-month trial, Hb significantly increased by 15·8, 17·3 and 21·8 g/l, and ferritin
by 2·8, 3·6 and 11·0mg/l, in the I, IF and IM groups compared with placebo. Polarisation (r) and microviscosity (h) decreased significantly in
other groups compared with placebo, indicating an increase in membrane fluidity. Significant decreases of r and h values compared with
group C were 0·033 and 0·959 for group I, 0·037 and 1·074 for group IF and 0·064 and 1·865 for group IM, respectively. In addition, significant
increases of glutathione peroxidase activities and decreases of malondialdehyde were shown in all treated groups, as well as increases of plasma
retinol and urine riboflavin in group IM. The findings show that supplementation with Fe and particularly in combination with vitamins could
improve the haematological status as well as oxidative stress and erythrocyte membrane fluidity.
Micronutrients: Anaemia: Pregnant women: Oxidative stress: Membrane fluidity
Fe is an essential trace element that is frequently deficient both
in infants and in women of reproductive age from developing
countries. Prevalence of anaemia is still high in rural areas in
China(1). Fe deficiency is associated with anaemia(2) and
impairment of Fe-dependent enzymes and proteins(3). Fe
supplementation is almost universally recommended during
pregnancy to correct or prevent deficiency(4). However, the
pathological accumulation of the metal within the tissues
aggravates the generation of reactive oxygen species and
elicits toxic effects, which are mainly related to oxidative
stress(5). Fe plays a central role in generating harmful
oxygen species. Its redox cycling promotes the Fenton
reaction, producing the potent oxidant hydroxyl radical(6).
Reactive oxygen species can alter the chemical and physical
properties of cell membranes leading to a structural alteration,
which could modify membrane activity and cause a reduction
in membrane fluidity that can be assessed in the erythrocyte(7).
Several studies have reported that free radicals, including
chemical scavengers or antioxidant molecules, superoxide
dismutase (SOD) and glutathione peroxidase (GSH-Px), are
relatively low in normal conditions due to active defence
systems. In rats, both Fe deficiency and excess result in free
radical mitochondrial damage(8). The excessive superoxide
produced by abnormal redox reactions can also cause bio-
chemical modification in erythrocyte membrane proteins.
This could result in changes in membrane structure or trans-
membrane transport that may exert a variety of cytotoxic
effects(9), and affect membrane viscoelasticity.
In relation to pregnancy, there was a report that supplemen-
tation with vitamin C (1000 mg/d) and vitamin E (400 mg/d)
might be beneficial in pregnant women with increased risk
of pre-eclampsia, a complication in which oxidation is an
important feature(10). Two large randomised trials showed,
however, that supplementation with vitamins C and E during
the second trimester did not reduce the pre-eclampsia(11,12).
The administration of an Fe supplement with vitamin C to
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twenty-seven women during the third trimester of pregnancy
significantly increased maternal Fe status as well as an
indicator of lipid peroxidation, compared with controls(13).
Increased oxidative stress was reported to occur in uncompli-
cated pregnancy and to be counteracted by a high level of
plasma vitamin E(14).
Thus, provision of a moderate dose of Fe (100 mg/d) might
be deleterious in certain circumstances and not in others, with
respect to the possible generation of reactive oxygen species.
Therefore, the purpose of the study was to investigate the
effect of supplementation with Fe only and Fe combined with
folic acid or with folic acid, retinol and riboflavin on haemo-
tological status, oxidative stress parameters, such as SOD,
GSH-Px and malondialdehyde (MDA) level, and erythrocyte
membrane fluidity in anaemic pregnant women during the trial.
Materials and methods
Participants
The study was a 2-month intervention trial conducted on the
effect of (1) Fe, (2) Fe and folic acid and (3) Fe, folic acid,
retinol and riboflavin on indicators of oxidative stress, com-
pared with placebo. Participants were recruited between
March 2004 and September 2006 from the community hospi-
tals of Shen County in the central area of China. A total of
366 pregnant women consented to participate and fulfilled
the other eligibility criteria of having taken no dietary sup-
plements during the past 2 months and having no abnormal
pregnancy response. Finally, a random sample of 164 anaemic
pregnant women (80 g/l , Hb ,110 g/l), 12–24 weeks ges-
tation, and 20–35 years old, were randomly allocated to
four groups in the order of recruitment: group C (n 41) was
the placebo control group, group I (n 41) was supplemented
daily with 60 mg Fe as ferrous sulphate, group IF (n 41)
was supplemented daily with 60 mg Fe and 400mg folic
acid, group IM (n 41) was supplemented daily with 60 mg
Fe, 400mg folic acid, 2 mg retinol and 1 mg riboflavin. The
sample size was calculated based on a difference in Hb
change (d) of 5 g/l between the intervention and placebo
groups, and a standard error of 6·67 g/l was derived from
the study reported by Suharno et al.(15). Considering a 5 %
(a ¼ 0·05) significance level and a power of 0·80 (b ¼ 0·20),
the total number of subjects required for the study was 164.
Treatments were blindly assigned to the groups, leaving the
key in a sealed envelope with an independent person in
the institute. The capsules were labelled in red, yellow, green
and blue colour, and manufactured by Hurun company
(a Chinese food-additives company, Beijing, China). Trial par-
ticipants and the research team were unaware of the treatment
assignment. The trial was unblinded after analysis of the
primary outcomes.
Pregnant women were enrolled after obtaining written
informed consent and had a baseline interview on character-
istics, such as age, gestation, and previous pregnancies. In
each community, a local female community health worker
called ‘village nurse’ was responsible for the recruitment
and distribution of the supplements. After ascertainment of eli-
gibility, consenting women were enrolled in the study, had a
baseline interview and started with their allocated supplements
to be taken daily for a period of 2 months. Women were
home-visited once a week by the village nurse to replenish
supplements and to monitor compliance by counting and
recording the number of supplements that were taken. The
nurse also provided counselling about the possible side effects.
The present study was conducted according to the guide-
lines laid down in the Declaration of Helsinki, and all the
procedures involving human subjects were approved by the
ethics committee of Medical College of Qingdao University
(QY-ETC2002821).
Sample collection and laboratory analyses
Before and at the end of the intervention, overnight fasting
(.12 h) blood samples were collected between 6.00 and
8.00 hours. Moreover, daily sample collection was evenly dis-
tributed over each of the four groups. The urine first passed
was discarded, and the next 10 ml was collected in dark con-
tainers, which were immediately aliquoted, for riboflavin and
creatinine analysis. The samples were transported on dry-ice
and stored frozen at 2808C until analysis. The baseline
and final samples were analysed in duplicate during the
same analytic run.
Plasma retinol concentrations were measured by reversed-
phase HPLC (Beckman 5000 with detector of 168; Fullerton,
CA, USA), and the within-assay and between assay CV were 3
and 8 %, respectively(16). Folic acid in plasma was measured
by the RIA method. The nutritional status of riboflavin was
determined by the ratio of urine riboflavin:creatinine(17).
Hb concentration was measured by the cyanomethaemoglo-
bin method by using HemoCue for confirmation. The cutoff
value of anaemia was Hb , 110 g/l. Measurements of serum
ferritin were performed by RIA(18), as described by the man-
ufacturer (The North Biological Technology Institute, Beijing,
China). Plasma Fe concentrations were analysed by atomic
absorption spectrometry on an Analyst 3100 Analyser
(Perkin Elmer Life Sciences, Wellesley, MA, USA).
The activities of SOD and GSH-Px were determined in
plasma(19) as U/ml and IU/ml, respectively. The MDA concen-
tration was determined by using the thiobarbituric acid reac-
tion, and calculated by comparing the absorbance values of
the samples with those of standard MDA solutions. Results
were expressed as nmol/ml blood. Additionally, routine par-
ameters were also studied in plasma from the subjects(20).
The erythrocyte membrane fluidity can be measured by flu-
orescence polarisation (r) and microviscosity (h). To evaluate
membrane fluidity by fluorescence spectroscopy, cell suspen-
sions were incubated with the fluorescence probes (final con-
centration 1026 M). Erythrocytes were washed with the
physiological saline, and suspended in the PBS solution
(pH ¼ 7·4) at 0·01 mol/l. To the erythrocytes suspension,
1,6-diphenyl-1,3,5-hexatriene (2 £ 1026 mol/l) was added
before being incubated in a water-bath at 258C for
15 min(21). Samples were illuminated with the linear (verti-
cally – V or horizontally – H) polarised monochromatic
light (lex), and the emitted fluorescence intensities (I – in
arbitrary units) parallel or perpendicular to the direction of
the excitation beam were recorded. The suspension was exam-
ined by spectrofluorophotometer (Perkin Elmer fluorescence
spectrometer, LS-50) with the excitation wavelength of
320 nm and emission wavelength of 430 nm(22,23); r and h
of the erythrocyte membrane were calculated by the following


















r ¼ IVV 2 GIVH=IVV þ GIVH;h ¼ 2r=0·462 r
where the indices V and H denote the vertical and horizontal
position of the polariser in the excitation and the fluorescence
beams, respectively. G is an instrumental correction factor
equal to (IVV/IVH). The subscript H refers to the horizontally
polarised excitation beam. IVV and IVH represent the
components of the corrected polarised emission parallel and
perpendicular to vertical direction, respectively(24,25).
Statistical analysis
Categorical data are presented as frequencies, such as preva-
lence of anaemia. Continuous data, haematological indicators,
vitamin concentrations, oxidative parameters, h and r values
were normally distributed and presented as means and stan-
dard deviations. Baseline variables were compared across
the treatment groups using a general linear model ANOVA.
Mean changes over the intervention period and differences
between the groups were tested with Student t tests for haema-
tological indicators, vitamin levels, oxidative indicators, h and
r values. A two-sided P,0·05 was considered as the
significant level for all tests.
Results
Complete data were available for 145 of the original 164
pregnant women. Nineteen women did not complete the trial
for the following reasons: five women were moved to other
villages, eleven women were stopped taking supplements
and three women were not willing to provide a second
blood sample. There were no substantial differences between
the remaining groups in any of the baseline characteristics
(Fig. 1 and Table 1). Compared with the means of haematolo-
gical status at the start of the trial, significant decreases of
Hb, plasma Fe and ferritin values were found in the C group
2 months later, whereas the levels of haematological status
were significantly increased in the I, IF and IM groups after
2 months supplementation (Fig. 2).
After the 2 months supplementation, there were considerable
increases in haematological indicators in the I, IF and IM groups
compared with the C group: 15·8, 17·3 and 21·8 g/l for Hb
(all P values ,0·001); 4·7, 5·5 and 9·7mmol/l for plasma
Fe (all P values ,0·001); 2·8, 3·6 and 11·0mg/l for ferritin
(all P values ,0·001). The increases of plasma retinol and
urine riboflavin in the IM group were 267·4mg/l (P,0·001))
and 61·59 mg/g creatinine (P,0·001), respectively. For
plasma folic acid, the increase was 4·06mg/l in the IF group
(P,0·001) and 4·65mg/l in the IM group (P,0·001), all
compared with the C group (Table 2). The increases in all
haematological and vitamin indicators in the IM group were
significantly greater than in the I group (all P values ,0·001).
Erythrocyte membrane fluidity was evaluated using fluor-
escence r and h; lower values indicate better membrane fluidity.
After the trial, the r and h values, compared with the C group,
decreased by 0·033 and 0·959 for the I group, 0·037 and 1·074
for the IF group, and 0·064 and 1·865 for the IM group, respect-
ively. The r and h values in the IM compared with those in the I
group decreased by 0·031 and 0·906 (all P values,0·05) (Table 3).
164 anaemic pregnant women screened
at 12–24 weeks of gestation
Placebo
(n 41)










Moved out: 1 
Total lost: 7
Stop treatment: 3














2 months trial, home visit once a week
Fig. 1. The trial profile. The trial enrolment was conducted from 2004 to 2006. A total of 366 women were eligible, from whom we took a random sample of 164,
who were allocated to the intervention groups by order of randomisation. In the intervention study, complete data were available on 145 pregnant women, which is
88·4 % of the original number of 164 pregnant women. Nineteen women did not complete the trial. However, there were no substantial differences between the
groups in any of the baseline characteristics.

















The changes in oxidative stress parameters are presented in
Table 3. Compared with the C group, increases of GSH-Px
activities were 37·7, 43·4 and 87·9 IU/ml in the I, IF and IM
groups, respectively; the levels of MDA decreased by 0·55,
1·06 and 2·56mmol/l. Moreover, the increase of GSH-Px
activity and decrease of MDA level were 50·2 IU/ml and
2·01mmol/l greater in the IM group compared with the
I group (all P values ,0·01); however, there were no impor-
tant changes in SOD activities during the trial.
Discussion
After 2 months of supplementation with Fe and/or vitamins,
anaemic pregnant women significantly improved in erythro-
cyte membrane fluidity and antioxidative markers, in addition
to increases of Hb concentration, plasma Fe, ferritin, retinol
and urine riboflavin concentrations. Most of the effects were
greatest in the Fe combined with multivitamin (IM) group.
Up to now, only few studies have evaluated the changes in
both haematological status and erythrocyte membrane fluidity
after Fe supplementation in anaemic pregnant women, possibly
because erythrocyte membrane preparation is quite laborious.
The present study had a relatively large study population and
it was carried out under difficult circumstances in a poor rural
part of China. Unfortunately, there was a small proportion of
women who dropped out after treatment allocation, only in
the supplement groups. Some subjects stopped treatment
because of possible side effects, including nausea, abdominal
discomfort and vomiting(26). For other subjects, data were not
complete because of an insufficient amount of plasma, subjects
refusing to give a second blood sample or they were moving out
of the area. This did not result in imbalances with respect to
important baseline characteristics. Compliance of the remaining
participants was almost complete, probably because the study
subjects were motivated by the offer of free of charge medical
care, and bi-weekly visits by village nurses.
In fact, retinol and riboflavin deficiencies tend to coexist in
anaemic pregnant women in developing countries or in impo-
verished settings(27). In a previous study(1), high percentages of
subnormal vitamin A and subnormal riboflavin were 23 and
38 % in anaemic pregnant women. Vitamin A deficiency
may also result in anaemia in human subjects and animals
that can be reversed only by vitamin A supplementation(28).
Biochemical evidence of riboflavin deficiency was documen-
ted during the third trimester of pregnancy(29). Retinol or ribo-
flavin plus Fe supplementation could improve haematological
status better than Fe alone(30). The reduced prevalence of anae-
mia (Hb , 110 g/l) and Fe-deficiency anaemia was signifi-
cantly greater in the groups supplemented with retinol and/or
riboflavin than in the groups supplemented with Fe. Retinol
status is a putative factor for improved Fe status or Fe absorp-
tion. Vitamin A and b-carotene may form a complex with Fe,
keeping it soluble in the intestinal lumen as well as preventing
the inhibitory factors on Fe absorption(31). Moreover, gastro-
intestinal symptoms were less prevalent in the group sup-
plemented with Fe, folic acid and retinol than in the group
supplemented with Fe only, and improved well-being was
more prevalent in the groups that received additional retinol
and/or riboflavin than in the group that received Fe only.
Table 1. Baseline characteristics of Chinese anaemic pregnant women in four groups*
(Mean values and standard deviations)
All baseline C I IF IM
Characteristics Mean SD Mean SD Mean SD Mean SD Mean SD F P†
Subjects (n) 145 41 35 34 35
Age (years) 27·4 3·4 27·3 3·4 27·8 3·5 27·4 3·1 27·0 3·7 0·62 0·601
Gravidity (n) 1·3 0·4 1·3 0·5 1·3 0·5 1·3 0·4 1·2 0·4 0·86 0·464
Gestational stage (week) 20·9 4·7 21·1 4·8 21·9 4·4 20·0 4·8 20·3 4·5 1·28 0·285
Hb (g/l) 99·8 6·5 101·7 8·7 99·5 5·6 99·0 4·8 98·8 5·7 0·76 0·519
Plasma Fe (mmol/l) 12·2 2·1 12·8 2·8 11·6 2·3 11·7 1·5 12·3 1·2 1·88 0·136
Ferritin (mg/l) 12·1 3·8 12·6 5·1 12·8 2·6 11·9 3·3 10·9 3·6 0·76 0·521
Folate (mg/l) 3·90 1·84 4·10 1·86 3·68 1·65 4·13 1·95 3·66 1·92 0·21 0·891
Retinol (mg/l)) 296·8 67·5 306·9 79·5 301·3 62·2 297·8 61·3 279·3 62·0 2·8 8·42
Riboflavin (mg/g creatinine ratio) 41·95 15·39 42·29 17·64 42·98 14·10 42·52 14·75 39·96 14·90 0·08 0·969
Malondialdehyde (mmol/l) 4·97 1·34 4·95 1·10 5·38 1·77 4·68 1·11 4·88 1·28 1·57 0·200
Superoxide dismutase (U/ml) 73·3 26·2 73·3 35·1 72·3 22·4 73·8 23·3 73·7 20·7 0·02 0·995
Glutathione peroxidase (IU/ml) 116·6 29·0 108·3 26·7 116·3 27·1 124·2 30·7 119·4 30·2 2·06 0·108

































Fig. 2. A comparison of haematological status between before and after
the trial. A represent the mean and standard deviation of Hb concentration,
for plasma iron concentration and for ferritin with significant changes
between groups; group C as placebo, group I supplemented daily with 60 mg
iron, IF with 60 mg iron and 400mg folic acid and IM with 60 mg iron, 400mg
folic acid, 2 mg retinol and 1 mg riboflavin, respectively. * Mean values were
significantly different from that of the control group (P,0·05).

















Although fluorescence r was used to assess membrane
fluidity in the past decades, presently, it is frequently applied
in estimating oxidative stress(32), erythrocyte aggregation(33),
understanding of membrane protein function(34), etc. The non-
invasiveness of the method makes it especially suitable for
clinical applications(35). Pregnancy is a condition exhibiting
increased susceptibility to oxidative stress. In normal preg-
nancy, the implantation process, proliferation, differentiation
and trophoblast invasion produce reactive oxygen
species(36,37). Transitional metals, especially Fe, which are
particularly abundant in the placenta, are important in the pro-
duction of these free radicals(38). Increased Fe levels may be
responsible for placental oxidative stress and abnormalities
in antioxidants(39). Fe overload could promote the generation
of free radicals and result in cellular damage(12), and Fe sup-
plementation with 100 mg/d or overload might risk increased
MDA levels or oxidative stress in the maternal plasma and
the placenta during pregnancy(40), but in a previous study,
low doses of oral ferrous Fe (36 mg/d) did not unfavourably
change the physiological pattern of parameters of oxi-
dation(41). However, in the present study, haemotological
status was improved and MDA levels decreased in anaemic
pregnant women after a daily supplementation of 60 mg Fe,
which might be attributed to the supplementation with a low
dose of Fe and a combination of three vitamins. Erythrocyte
membrane fluidity also improved, which indicates that the
Fe supplementation did not reduce, but possibly even
improved, the antioxidant capacity. There are no documented
side effects of Fe supplements below 100 mg/d(42). In the pre-
sent study, Fe combined with multivitamin supplementation
showed a more favourable effect than Fe alone, and this
dose of Fe supplementation did not increase Hb levels
higher than the optimal concentration needed for O2
delivery(43). A daily supplementation of 100 mg Fe as ferrous
sulphate was recommended during the second half of
pregnancy to address the corresponding Fe requirements(2),
and the risks associated with oxidative stress were not
observed in women supplemented with 120 mg Fe once
or twice per week(38). Suggested guidelines are ferritin
,30mg/l: 80–100 mg ferrous Fe daily, for which there are
no documented side effects(42).
Several studies have shown that micronutrient supplemen-
tation improves the GSH-Px activities and decreases the
levels of MDA(20,44), and antioxidant supplementation was
associated with better maternal and perinatal outcome in preg-
nant women with low antioxidant status than supplementation
with Fe and folate alone(45). However, we did not find any
change of SOD activity during the trial. Some studies
showed similar results(46) and even a decrease of SOD activity
after antioxidant supplementation(47). This aspect deserves
further study. In the present study, antioxidant defences
and oxidative stress appear to be favourably modulated by
Table 2. Comparison of haematological and vitamin status between control and supplemented groups* after the trial
(Mean values and standard deviations)
C I IF IM
Indicators Mean SD Mean SD Mean SD Mean SD F P†
Subjects (n) 41 35 34 35
Hb (g/l) 99·0a 5·5 114·8b 8·6 116·3c 6·0 120·8d 6·1 80·38 0·000
Plasma Fe (mmol/l) 11·6a 1·9 16·3b 0·5 17·1c 0·8 21·3d 1·5 344·95 0·000
Ferritin (mg/l) 11·4a 3·4 14·2b 1·2 15·0c 2·2 22·4d 6·4 55·14 0·000
Folic acid (mg/l) 3·52a 1·50 4·12 1·29 7·58c 1·67 8·17d 1·74 83·44 0·000
Retinol (mg/l) 290·5a 63·4 313·1 55·8 314·8 49·3 557·9d 90·0 1296·8 0·000
Riboflavin (mg/g creatinine ratio) 39·79a 15·56 47·17 20·03 47·05 19·16 101·38d 46·40 37·91 0·000
a,b,c,d Mean values within a row with unlike superscript letters were significantly different (P,0·05, independent t test).
* Group C, placebo; group I, 60 mg ferrous sulphate; group IF, in addition 400mg folic acid; group IM, in addition 2 mg retinol and 1 mg riboflavin.
† One-way ANOVA.
Table 3. Comparison of membrane fluidity and oxidative stress status between control and supplemented groups* after the trial
(Mean values and standard deviations)
C I IF IM
Indicators Mean SD Mean SD Mean SD Mean SD F P†
Subjects (n) 41 35 34 35
Membrane fluidity
r 0·330a 0·052 0·297b 0·012 0·293c 0·008 0·266d 0·009 30·81 0·000
h 4·593a 2·088 3·634b 0·419 3·519c 0·243 2·728d 0·178 17·12 0·000
Oxidative stress
GSH-Px (IU/ml) 115·1a 23·5 152·8b 60·0 158·5c 63·8 203·0d 88·5 12·62 0·000
SOD (U/ml) 72·5 35·9 76·0 19·6 75·1 17·7 72·9 18·3 0·17 0·915
MDA (mmol/l) 5·04a 1·12 4·49b 0·57 3·98c 0·60 2·48d 0·46 78·34 0·000
r, Polarisation; h, microviscosity; GSH-Px, glutathione peroxidase; SOD, superoxide dismutase; MDA, malondialdehyde.
a,b,c,d Mean values within a row with unlike superscript letters were significantly different (P,0·05; independent t test).
* Group C, placebo; group I, 60 mg ferrous sulphate; group IF, in addition 400mg folic acid; group IM, in addition 2 mg retinol and 1 mg riboflavin.
† One-way ANOVA.

















Fe supplementation alone. Such findings have not been
reported in anaemic pregnant women before, and further
mechanistic studies are to be expected.
Taken together, subjects had more antioxidative capacity,
i.e. lower levels of circulating lipid peroxidation products
(MDA), and higher GSH-Px activity and higher vitamin concen-
trations after 2 months of supplementation. The improvement
of erythrocyte membrane fluidity, as apparent in decreases
of r and h, indicates that the erythrocytes accumulate fewer
oxidative lesions. Moreover, the increase in the plasma anti-
oxidant status could contribute to the prevention of PUFA
peroxidation of erythrocytes. This evidence could also explain
the lower peroxidation found in subjects supplemented with
Fe and vitamins in comparison with the control. Fe combined
with multivitamin supplementation showed a more favourable
effect than Fe only. We could not find any indication
of an increase of oxidative stress after Fe supplementation.
On the contrary, a moderate dose of Fe, preferably combined
with multivitamin supplementation, may be beneficial both
by improving anaemia and by decreasing the status of oxidative
stress during pregnancy.
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